AlphaFold predicted structure
BRPF1 · P55201

Mean pLDDT
67.5/ 100
Low
1,214 residues
Confidence breakdown
- Very high(≥ 90)27%
- Confident(70–90)29%
- Low(50–70)9%
- Very low(< 50)34%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
bromodomain and PHD finger containing 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownStructural eye disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownintellectual developmental disorder with dysmorphic facies and ptosis
hereditary disease
neurodegenerative disease
Intellectual disability
neurodevelopmental disorder
syndromic complex neurodevelopmental disorder
Global developmental delay
sudden unexplained death in childhood
lysosomal storage disease
developmental disability
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Peregrin
Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, which have a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:24065767, PubMed:27939640). Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac) (PubMed:24065767). Some HAT complexes preferentially mediate histone H3 'Lys-23' (H3K23ac) acetylation (PubMed:27939640). Positively regulates the transcription of RUNX1 and RUNX2 (PubMed:18794358)
BRPF1 · P55201

Mean pLDDT
67.5/ 100
Low
1,214 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0